Skip to main content
Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
2.630
-0.430 (-14.05%)
At close: Dec 20, 2024, 4:00 PM
2.750
+0.120 (4.56%)
After-hours: Dec 20, 2024, 6:41 PM EST

Nexalin Technology Revenue

Nexalin Technology had revenue of $36.03K in the quarter ending September 30, 2024, with 49.43% growth. This brings the company's revenue in the last twelve months to $162.08K, up 26.00% year-over-year. In the year 2023, Nexalin Technology had annual revenue of $110.75K, down -91.62%.

Revenue (ttm)
$162.08K
Revenue Growth
+26.00%
P/S Ratio
134.91
Revenue / Employee
$27,013
Employees
6
Market Cap
33.83M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023110.75K-1.21M-91.62%
Dec 31, 20221.32M1.18M817.20%
Dec 31, 2021144.07K-98.85K-40.69%
Dec 31, 2020242.91K35.53K17.13%
Dec 31, 2019207.38K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Neuronetics 72.71M
CASI Pharmaceuticals 22.06M
SCYNEXIS 8.57M
Lexaria Bioscience 464.28K
Daxor 154.21K
Revenue Rankings

NXL News

More News